During the 18th Annual Symposium on Pancreatic Cancer hosted by the Hirshberg Foundation, Dr. Eileen O’Reilly from Memorial Sloan Kettering Cancer Center provided an overview of the latest treatments for pancreatic cancer and discussed the genetics of the disease. She also covered emerging targets, immunotherapy, and vaccine approaches currently in development.